Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y Reconstruction

STATUS

Recruiting
End date

Mar 31, 2024
participants needed

148
sponsor

Tianjin Medical University Cancer Institute and Hospital

Updated on 10 April 2022

See if I qualify

gastrectomy

lymphadenectomy

adenocarcinoma

Summary

The aim of this study is intending to provide the optimal procedures of the peristaltic direction of gastrointestinal anastomosis in Roux-en-Y reconstruction after distal curative gastrectomy for gastric cancer, which can provide the best operation mode of Roux-en-Y anastomosis in digestive tract reconstruction during distal gastrectomy for reducing postoperative complications and improving quality of life for patients.

Description

In this study, all 148 the included patients will underwent the distal curative gastrectomy for gastric cancer and will be performed the Roux-en-Y reconstruction for gastrointestinal anastomosis. Of them, 74 patients will be randomized in the group undergoing with the isoperistaltic anastomosis in the Roux-en-Y reconstruction procedure. Meanwhile, the other 74 cases will be randomized in the group undergoing with the antiperistaltic anastomosis in the Roux-en-Y reconstruction procedure. Then, we will evaluate the differencies of effects of early recovery postoperatively (exhaust, defecation, eating, residual stomach peristalsis, length of hospital stay, etc.) and late gastrointestinal effects (bile reflux, residual gastritis, gastric emptying function, etc.) between above two group of patients, which will make an important contribution to reduce medical costs and potential improvements of the prognosis after distal curative gastrectomy for gastric cancer.

Details

Condition	Peristaltic Direction, Roux-en-Y Gastrointestinal Anastomosis, Gastric Cancer
Treatment	Direction procedure of gastrointestinal anastomosis in Roux-en-Y reconstruction
Clinical Study Identifier	NCT04801459
Sponsor	Tianjin Medical University Cancer Institute and Hospital
Last Modified on	10 April 2022

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	) Pathological examination confirmation the adenocarcinoma of stomach before surgery
	) Physical conditions compliance with the requirements for curative gastrectomy
	) Consent to undergo the D2 lymphadenectomy, and the dissected proportion of stomach no less than 2/3
	) Comply with the protocol during the whole study period
	) No neoadjuvant therapy administration
	) Sign informed consent and permission of withdraw in the whole study period
	) Consent to provide the tissue specimens after surgery for this study
	) Estimation the overall survival after surgery no less than 6 months
	) No anesthesia or operation contraindication disease
	) cT1-4N0-2M0 stage demonstration by CT and endoscopic ultrasonography examinations
	) Negative cytological detection in operation
	) No seriously concomitance's diseases
	) Karnofsky Performance Scores (KPS) more than 60
	) Examined lymph node count no less than 16
Exclusion Criteria
	) Women during pregnant stage and breast-feed stage
	) Women of childbearing age without any contraceptive measures
	) Severe congestive heart failure, frequent arrhythmia, or myocardial infarction within 12 months
	) Immunosuppressive therapists for organ transplantation
	) Seriously uncontrolled recurrent infection
	) other malignant tumors
	) No abilities of self-knowledge or mental disorders
	) Participating in other clinical trials
	) Siewert I and II esophagogastric junction tumors
	) Serious internal diseases obstruction surgery

How to participate?

Step 1 Connect with a study center

Select a site
Send a message

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Primary Contact

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

gastrectomy

lymphadenectomy

adenocarcinoma

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Edit Delete

Added by •

•

Private

Edit Delete

Reply by • • Private

Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

Enter the passcode

The passcode will expire in None.

Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y Reconstruction